sk&f 107260 has been researched along with fibrinogen in 1 studies
Studies (sk&f 107260) | Trials (sk&f 107260) | Recent Studies (post-2010) (sk&f 107260) | Studies (fibrinogen) | Trials (fibrinogen) | Recent Studies (post-2010) (fibrinogen) |
---|---|---|---|---|---|
11 | 0 | 0 | 34,477 | 1,707 | 7,083 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, FE; Bennett, D; Bondinell, W; Chen, W; Heys, JR; Hwang, SM; Johanson, K; Ku, TW; Landvatter, SW; Nichols, AJ; Powers, DA; Samanen, J; Stadel, JM; Wong, A | 1 |
1 other study(ies) available for sk&f 107260 and fibrinogen
Article | Year |
---|---|
Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
Topics: Binding, Competitive; Blood Platelets; Cations, Divalent; Dose-Response Relationship, Drug; Fibrinogen; Humans; Intercellular Signaling Peptides and Proteins; Oligopeptides; Peptides; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 1998 |